Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2021

Jan 5, 2021

32044_dirs_2021-01-05_8ac4ef5d-9486-4625-96d6-c8e7ae2e7027.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2021-01-02

Reporting Person: Sabzevari Helen (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-01-02 Common Stock M 9766 Acquired 411911 Direct
2021-01-04 Common Stock S 5279 $10.16 Disposed 406632 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-02 Restricted Stock Units $ M 9766 Disposed Common Stock (9766) Direct

Footnotes

F1: Each restricted unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.

F3: The RSUs were granted on January 2, 2018, and the remaining RSUs vest on January 2, 2022.